29/10/2025
Scientists have achieved a groundbreaking milestone by using genetically modified microbes to target and shrink tumours. These specially engineered microbes are designed to seek out cancer cells while sparing healthy tissue, offering a precision approach that could revolutionise cancer treatment.
In laboratory studies, the microbes successfully infiltrated tumours, releasing therapeutic compounds that slowed growth and, in some cases, reduced tumour size significantly. This approach represents a new frontier in oncology, combining synthetic biology with medicine to create targeted, effective therapies.
Experts believe this method could pave the way for treatments with fewer side effects compared to traditional chemotherapy and radiation. While still in early stages, clinical trials are being planned to explore safety and effectiveness in humans.
This discovery underscores the incredible potential of biotechnology to transform medicine and offers hope for millions affected by cancer worldwide. The era of living medicines may be closer than we ever imagined.
